Media

Innoplexus unveiled iPlexus TM at Bio-IT, 2017, Boston. iPlexus.ai is an end-to-end platform for Life Sciences which leverages Artificial Intelligence (AI) to cut the drug development time, from synthesis to approval, significantly. It generates continuous intelligence and insights, across discovery, clinical development, regulatory and commercial stages of drug development, spanning all major therapeutic areas and indications. It has modules for Competitive Intelligence, […]

Read more

3 Ways Big Data and Analytics are Making Big Changes in Healthcare The technologies behind the next wave in healthcare innovation. Information is the new currency of innovation. With data flowing from countless new sources every day, the opportunities to dig in and learn more about the world around us have never been greater. Sometimes […]

Read more

Are Indian Tech Start-ups Robust Enough To Run Fast With Nation’s Digital Drive? The Zomato security breach puts a question mark on the information handling ability of start-ups The digital drive in India has altered the functioning of the industrial sector and put it on a fast track. In today’s cut-throat competition, every small or big […]

Read more

  Excited to announce that Innoplexus is a gold sponsor of Bio-IT World Conference & Expo which is a 3 day event being held from 23rd May to 25th May 2017 at the Seaport World Trade Center in Boston, United States Of America. This event will feature various sectors from the Bioinformatics industry. Our Founder […]

Read more

Innoplexus launches iPlexus to transform decision support in the Life Sciences Industry Innoplexus, the technology and product development company focused on AI and advanced analytics, announced the launch of its product iPlexus, an end to end platform for Life Sciences which leverages artificial intelligence to generate continuous intelligence and insights across discovery, clinical development, regulatory […]

Read more

Innoplexus is proud to announce our collaboration with the Regional Cancer Centre, Gwalior. Innoplexus has executed an MoU to provide an academic license for its iPlexusᵀᴹ platform to RCC, Gwalior, India. The academic license allows doctors and researchers with free access to iPlexusᵀᴹ. Doctors and researchers will be able to gain insights into the latest […]

Read more

Innoplexus, a Germany- and India-based Data as a Service (DaaS) startup, has closed an undisclosed sum in pre-Series A funding from HCS, a Germany-based Venture VC firm. With the capital, the startup plans to file more patent applications, further develop its trademark platform iPlexusTM, and invest in marketing.

Read more

Innoplexus raises undisclosed sum in Pre-Series A from Germany-based HCS Germany and India-based Innoplexus, has raised their Pre-Series A funding from HCS, a Germany-based Venture Capital Fund. With the fresh capital, Innoplexus plans to file more patent applications, further develop their trademark platform, iPlexus, and invest in marketing. Founded in 2011, Innoplexus helps Life Sciences […]

Read more

DaaS Startup Innoplexus Secures Pre-Series A Funding From German VC Fund HCS Germany and India based DaaS (Data as a Service) startup, Innoplexus has secured an undisclosed amount in its Pre-Series A round of funding from HCS, a Germany-based Venture Capital Fund. Post the investment, Hans-Christian Semmler, Managing shareholder of HCS will join as Chairman of […]

Read more